首页 | 本学科首页   官方微博 | 高级检索  
     

代谢物组学在糖尿病研究中的现状与进展
引用本文:张健,魏昕,洪战英,柴逸峰. 代谢物组学在糖尿病研究中的现状与进展[J]. 药学服务与研究, 2013, 0(6): 401-404
作者姓名:张健  魏昕  洪战英  柴逸峰
作者单位:[1]上海交通大学医学院附属新华医院药剂科,上海200092 [2]第二军医大学药学院药物分析学教研室上海市药物(中药)代谢产物研究重点实验室,上海200433
基金项目:上海市科学技术委员会科研计划项目(11DZ1972500)
摘    要:糖尿病是代谢相关疾病,其发生过程必然伴随着代谢产物的改变。因其诊断标准和治疗方案已经十分明确,目前对糖尿病的研究主要集中在寻找早期生物标志物,期望其作为糖尿病相关代谢改变和胰岛素抵抗的早期筛查指标。近十年来代谢物组学研究快速发展,不仅为糖尿病诊断提供了新的思路,还可以通过发现新的生物标志物来预测糖尿病的发展情况。本文就目前代谢物组学在糖尿病研究中的现状和进展作简要综述。

关 键 词:代谢物组学  糖尿病  生物标志物  综述

Current situation and progress of metabolomics in diabetes
ZHANG Jian,WEI Xin,HONG ZhanYing,CHAI YiFeng. Current situation and progress of metabolomics in diabetes[J]. Pharmaceutical Care and Research, 2013, 0(6): 401-404
Authors:ZHANG Jian  WEI Xin  HONG ZhanYing  CHAI YiFeng
Affiliation:1. Department of Pharmacy, Xinhua Hospital Affiliated to School of Medicine, Shanghai Jiaotong University, Shanghai 200092,China; 2. Department of Pharmaceutical Analysis, School of Pharmacy, Second Military Medical University, Shanghai Key Laboratory for Pharmaceutical(Chinese Materia Medica) Metabolite Research,Shanghai 200433, China3
Abstract:Diabetes is a metabolism-related diseases, its process must be accompanied with the occurrence of metabolite changes. As diagnostic criteria and therapeutic management of diabetes are very clear, current researches are focused on discovery of early biomarkers, which can be used as screening indicators for patients in early stage of diabetes and insulin resist- ance. Over the past decade, metabolomics has developed rapidly, which not only provides new idea for the diagnosis of diabetes, but also supports new biomarkers for predicting the development of disease. This paper is an overview of present situation and advances on metabolomics in diabetes.
Keywords:metabolomics  diabetes mellitus  biomarkers  review
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号